Financhill
Back

Praxis Precision Medicines Quote, Financials, Valuation and Earnings

Unlock the Secret to Earning Monthly Income!

Limited spots act swiftly
Sell
34

PRAX
Praxis Precision Medicines

Last Price:
52.29
Seasonality Move:
-39.58%

7 Day Trial

ALL ACCESS PASS

$ 7

The little-known AI stock you need to read about now...

Get the name - FREE.

Praxis Precision Medicines Price Quote

$52.29
-0.46 (-0.87%)
(Updated: May 7, 2024 at 6:55 PM ET)

Praxis Precision Medicines Key Stats

Sell
34
Praxis Precision Medicines (PRAX) is a Sell

Day range:
$52.75 - $56.72
52-week range:
$12.45 - $67.21
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
141.83
P/B ratio:
10.02%

Volume:
137.4K
Avg. volume:
299.5K
1-year change:
222.63%
Market cap:
$698.3M
Revenue:
$2.4M
EPS:
$-22.59

How Much Does Praxis Precision Medicines Make?

Is Praxis Precision Medicines Growing As A Company?

Data Unavailable

Praxis Precision Medicines Stock Price Performance

What Is Praxis Precision Medicines 52-Week High & Low?

Praxis Precision Medicines Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Praxis Precision Medicines?

Is Praxis Precision Medicines Cash Flow Positive?

  • What Is PRAX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$111.1M
  • What Is Praxis Precision Medicines’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $91.9M
  • What Is Praxis Precision Medicines’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $39M

Praxis Precision Medicines Return On Invested Capital

  • Is Management Doing A Good Job?
    PRAX return on invested capital is -151.02%
  • What Is Praxis Precision Medicines Return On Assets?
    ROA measures how assets are converting to revenues and is -115.6%
  • What Is PRAX Return On Equity?
    ROE is a measure of profitability and is -153.09%

Praxis Precision Medicines Earnings Date & Stock Price

Praxis Precision Medicines Competitors

Praxis Precision Medicines Dividend Yield

Data Unavailable

Praxis Precision Medicines Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 6.24%
Revenue: 0% 930%

Analyst Recommendations

Buy Recommendations: 4
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 135.00
Upside from Last Price: 155.92%

Major Shareholders

  • How many PRAX shares are owned by institutional investors?
    28.1M PRAX shares are owned by institutional investors
  • How many PRAX shares are owned by insiders?
    750.2K PRAX shares are owned by insiders